Leadership, Planning and Evaluation

项目总结：领导、规划和评估 斯蒂芬·D·尼默，医学博士，2012年被任命为西尔维斯特综合癌症中心(西尔维斯特)主任。 在他的领导下，西尔维斯特经历了指数级的增长，在其敬业的领导团队的推动下， 它高度参与和经验丰富的外部顾问委员会(EAB)，它与大学的富有成效的关系 领导力，以及遵守精心制定的具有明确标准的2014-2018年战略计划， 时间表、目标和可交付成果。尼默在高级领导团队的协助下领导西尔维斯特 由1名副主任、6名副主任、1名副会长和主任医师组成 肿瘤学服务专线。总体而言，这个团队为署长提供了深思熟虑和重要的咨询意见， 包括促进西尔维斯特的基础科学、翻译科学、临床科学和人口科学发展的战略 研究组合；教育和培训活动；社区推广和参与能力；共享 资源支持；以及确定新的研究方向和创建新的计划和资金的能力 为其成员提供机会。除了西尔维斯特强大的高级领导团队提供的指导外， 西尔维斯特有七个内部审查委员会，它们提供建议并监督 执行西尔维斯特的活动和战略计划；包括空间执行委员会 拨款、内部资助计划(IFP)、科学指导委员会(SSC)、临床研究内部 咨询委员会(CRIAB)、癌症教育领导委员会(CELC)、社区外展和 接洽内部咨询委员会(COE IAB)。此外，两个外部咨询实体--外部 咨询委员会(EAB)和监督委员会(BOO)-提供对以下方面至关重要的建议和专业知识 西尔维斯特的成功。补充西尔维斯特的高级领导和内部和外部咨询 委员会是许多规划和评估工作(例如共享资源咨询小组(SR AG)) 和成员)，提交给科学指导和执行委员会审议和采取行动 委员会。总的来说，来自这些咨询实体的反馈使西尔维斯特能够获得有效的内部 和外部建议，设定优先事项，作出决策，并定义和评估中心的战略计划和 活动。这些活动推动了西尔维斯特的使命和愿景，最大限度地提高了中心推进全面 癌症研究议程，保持最高标准/质量的护理和研究，并为其独特的 集水区，一个具有无与伦比的多样性的地区。

PROJECT SUMMARY: LEADERSHIP, PLANNING, AND EVALUATION Stephen D. Nimer, MD, was appointed as Sylvester Comprehensive Cancer Center (Sylvester) Director in 2012. Under his leadership, Sylvester has experienced exponential growth, driven by its dedicated leadership team, its highly engaged and experienced External Advisory Board (EAB), its productive relationship with University leadership, and its adherence to a carefully constructed 2014-2018 Strategic Plan with clear standards, timelines, goals, and deliverables. Nimer leads Sylvester with the assistance of a senior leadership team comprised of a Deputy Director, six Associate Directors, an Associate Vice President, and Physician-in-Chief for the Oncology Service Line. Collectively, this team provides thoughtful and important counsel to the Director, including strategies that promote the growth of Sylvester’s basic, translational, clinical, and population science research portfolio; education and training activities; community outreach and engagement capabilities; shared resource support; and its ability to define new research directions and create new programs and funding opportunities for its members. In addition to the guidance offered by Sylvester’s robust senior leadership team, Sylvester has seven internal review committees that provide recommendations and oversee the implementation of Sylvester’s activities and strategic plans; including the Executive Committee, Space Allocation, Intramural Funding Program (IFP), Scientific Steering Committee (SSC), Clinical Research Internal Advisory Board (CRIAB), Cancer Education Leadership Council (CELC), and Community Outreach and Engagement Internal Advisory Board (COE IAB). Additionally, two external advisory entities—the External Advisory Board (EAB) and the Board of Overseers (BOO)—provide advice and expertise that is critical to Sylvester’s success. Supplementing Sylvester’s senior leadership and internal and external advisory committees are the many planning and evaluation efforts (e.g. Shared Resource Advisory Groups (SR AG) and Membership), which are presented for consideration and action to the Scientific Steering and Executive Committees. In aggregate, feedback from these advisory entities allows Sylvester to obtain effective internal and external advice, set priorities, make decisions, and define and evaluate the Center’s strategic plans and activities. These activities drive Sylvester’s mission and vision maximizing the Center’s ability to advance a full cancer research agenda, maintain the highest standard/quality of care and research, and serve its unique catchment area, one with unparalleled diversity.